ISPOR-FDA Summit 2020: Using Patient-Preference Information in Medical Device Regulatory Decisions: Benefit-Risk and Beyond
ISPOR and the US Food and Drug Administration (FDA) Center for Devices and Radiological Health (CDRH) will jointly sponsor a one-day Summit focusing on medical devices and the use of patient-preference information (PPI) in regulatory and other decision-making processes on March 31 at the FDA White Oak Campus in Silver Spring, MD, USA.
Key Objectives for discussion at the Summit are:
- To provide a forum for engaging all stakeholders including patient representatives, medical device industry, researchers, payers and policymakers, healthcare providers, assessors, and regulators to discuss and explore the role, challenges, and opportunities of using PPI.
- To identify possible barriers and highlight the opportunities for integrating PPI throughout the product lifecycle.
- To clarify the value of including PPI in regulatory, reimbursement, and patient-provider decision-making processes.
Special Pre-Event ISPOR Educational Webinar:
Patient Preference Information – What It Is and What It Is Not
Webinar available on March 4, 2020 at 12:00 Noon (EST)*
*Open to all interested in PPI (including those registered and not registered for the Summit)
Please note: On the day of the scheduled webinar, the first 500 registered participants will be accepted into the webinar. For those who are unable to attend or would like to review the webinar at a later date, the full-length webinar recording will be made available at the ISPOR Educational Webinar Series webpage approximately 2 weeks after the scheduled webinar. Reservations are on a first come, first served basis.